BioAtla, Inc. (BCAB) Q3 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bioatla, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:06.392 Good day, everyone, and welcome to today's BioATLA third quarter 2024 earnings call. 00:00:06.392 -- 00:00:09.974 At this time, all participants are in a listen-only mode. 00:00:09.974 -- 00:00:13.396 Later, you will have the opportunity to ask questions during the question and answer 00:00:13.396 -- 00:00:15.137 session. 00:00:15.137 -- 00:00:21.339 You may register to ask a question at any time by pressing star 1 on your telephone keypad. 00:00:21.340 -- 00:00:24.582 I will be standing by if you should need any assistance. 00:00:24.582 -- 00:00:29.944 It is now my pleasure to turn the conference over to Bruce Mackel with LifeSci Advisors. 00:00:31.277 -- 00:00:33.918 Thank you, Operator, and good afternoon, everyone. 00:00:33.918 -- 00:00:36.879 With me today on the phone from BioAtla are Dr. 00:00:36.879 -- 00:00:41.240 Jay Short, Chairman, CEO, and Co-Founder, 00:00:41.240 -- 00:00:44.641 and Richard Waldron, Chief Financial Officer. 00:00:44.641 -- 00:00:50.063 Following today's call, Dr. Eric Sievers, Chief Medical Officer, and Sherry Lydick, 00:00:50.063 -- 00:00:55.583 Chief Commercial Officer, will join Jay and Rick in a short Q&A. 00:00:55.583 -- 00:01:00.225 Earlier this afternoon, BioAtlas released financial results and a business update for 00:01:00.225 -- 00:01:03.435 the third quarter ended September 30, 2024. 00:01:03.967 -- 00:01:08.428 A copy of the press release and corporate presentation are available on the company's 00:01:08.428 -- 00:01:10.428 website. 00:01:10.729 -- 00:01:14.991 Before we begin, I'd like to remind everyone that statements made during this conference 00:01:14.991 -- 00:01:20.874 call will include forward-looking statements, including, but not limited to, 00:01:20.874 -- 00:01:25.714 statemen...